Seeing Is Believing
Currently out of the existing stock ratings of Nigel Dally, 56 are a SELL (16.33%), 170 are a HOLD (49.56%), 117 are a BUY (34.11%).
Analyst Nigel Dally, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 71.56% that have a potential upside of 34.71% achieved within 256 days.
Nigel Dally’s has documented 715 price targets and ratings displayed on 24 stocks. The coverage is on Financial Services, Healthcare, Communication Services, Basic Materials sectors.
Most recent stock forecast was given on EQH, Axa Equitable Holdings at 19-Aug-2024.
Analyst best performing recommendations are on ARQT (ARCUTIS BIOTHERAPEUTICS ).
The best stock recommendation documented was for ARQT (ARCUTIS BIOTHERAPEUTICS ) at 11/13/2023. The price target of $10 was fulfilled within 106 days with a profit of $7.89 (373.93%) receiving and performance score of 35.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$105
$0.29 (0.28%)
$100
8 days ago
(01-Nov-2024)
9/11 (81.82%)
$0.29 (0.28%)
119
Hold
$106
$1.29 (1.23%)
$90
30 days ago
(10-Oct-2024)
5/7 (71.43%)
$-5.61 (-5.03%)
25
Buy
$124
$19.29 (18.42%)
$115
30 days ago
(10-Oct-2024)
7/8 (87.5%)
$12.39 (11.10%)
98
Hold
$102
$-2.71 (-2.59%)
$74
1 months ago
(09-Oct-2024)
1/3 (33.33%)
$-9.06 (-8.16%)
28
Hold
$90
$-14.71 (-14.05%)
$83
1 months 6 days ago
(03-Oct-2024)
10/12 (83.33%)
$-23.53 (-20.73%)
240
Which stock is Nigel Dally is most bullish on?
Which stock is Nigel Dally is most reserved on?
What Year was the first public recommendation made by Nigel Dally?